Phytochemical investigation of the alkaloid extract of the aerial parts ofPsychotria nemorosa led to the isolation and characterization of 10 azepine-indole alkaloids, i.e., cimitrypazepine (1), fargesine (2), nemorosines A (3) and B (12), nemorosinosides A-F (4-9), as well as two β-carboline derivatives, 10hydroxyisodolichantoside (10) and 10-hydroxydolichantoside (11), an isoxazole alkaloid, nemorosinoside G (13), serotonin (14), bufotenine (15), and (S)-gentianol ( 16).Compounds 3-13 have not yet been described. These compounds were isolated by semipreparative HPLC and their structures determined by means of HRMS, NMR, and ECD measurements. In addition, the monoamine oxidase-A (MAO-A), MAO-B, acetylcholinesterase (AChE), and butyrylcholinesterase (BChE) inhibitory activities were evaluated. Alkaloids 1-3 inhibited the MAO-A activity with IC50 values of 1.4, 1.4, and 0.9 µM, respectively.
3The genus Psychotria, a member of the Rubiaceae family, has been widely studied because of its effects on the central nervous system (CNS). Some species of the genus, like P. viridis, are used to prepare Ayahuasca, a hallucinogenic beverage consumed by Amazon Indian tribes. 1 Recently, this preparation has attracted the attention of researchers due to its pharmacological potential, mainly to treat depression. [1][2][3] Other species have been described to treat dementia, which is corroborated by pharmacological studies. Their capacity to modulate key enzymes related to neurodegeneration, e.g. acetylcholinesterase (AChE), butyrylcholinesterase (BChE), monoamine oxidase A (MAO-A), MAO-B, and catechol-O-methyltransferase (COMT) has been demonstrated. [4][5][6][7][8][9][10][11][12][13] In this sense, Psychotria is considered as an important source of active compounds